Replies to post #539355 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

This article is actually pretty fair and gives both sides a fair hearing in the traditional fashion of objective journalism. We’d prefer just a “DCVax-L is awesome!” but a real journalist will not be pumping even if they feel that Dr. Liau is probably right as seems to be the case here.

[RobotDroid]

Whenever an article quotes Stat News I immediately discount the due diligence of the author. Quoting the ignorance of a doctor not connected to the trial is just bad journalism.

[Bright Boy]

This article is nothing but lies and misconceptions!! Probably written by Statnews!!!

[LearningEveryTrade]

freethink article, got some issues... https://www.freethink.com/health/brain-cancer-vaccine
The website ALS TDI defines "Post-Hoc" analysis as this "The act of looking at the data from a trial or other experiment in new ways after the study’s conclusion is called “post-hoc analysis.”

The Endpoint change was in the works well before the trial concluded, thus, Post-Hoc analysis impossible to be considered as to why endpoint was changed.

post-hoc is often used to create new trials based on subgroups found after a trial concludes.

[hankmanhub]

This is NOT a positive story. It is a soft bash. It leads with "People who got the treatment had double the average survival rate — but the results aren’t as clear as they seem."
Then it continues to quote Donald O’Rourke, a professor of neurosurgery who was in the STAT hit piece by AF with his false conclusion. then it quotes Merit Cudkowicz, the chief of neurology that this was a "post hoc analysis." Finally it concludes that : "To find out, though, Northwest Bio will need more trials, designed in such a way that the results are indisputable.

This is definitely a soft bash - not at all a good article about DCVAX.